Urinary trypsin inhibitor (UTI), a serine protease inhibitor, has been widely used as a drug for patients with acute inflammatory disorders such as disseminated intravascular coagulation, shock, and pancreatitis. However, direct contribution of UTI to inflammatory diseases has not been established. The present study analyzed acute inflammatory lung injury induced by lipopolysaccharide (LPS) in UTI-deficient (–/–) mice and corresponding wild-type (WT) mice. UTI (–/–) and WT mice were treated intratracheally with vehicle or LPS (125 μg/kg). The cellular profile of bronchoalveolar lavage fluid, lung water content, histology, and expression of proinflammatory molecules in the lung were evaluated. After LPS challenge, both genotypes of mice revealed neutrophilic lung inflammation and pulmonary edema. UTI (–/–) mice, however, showed more prominent infiltration of inflammatory cells and edema than WT mice. After LPS challenge in both genotypes of mice, the lung levels of mRNA and/or protein expression of interleukin-1β, macrophage inflammatory protein-1α, macrophage chemoattractant protein-1, keratinocyte chemoattractant, and intercellular adhesion molecule-1 (ICAM-1) were elevated in both groups, but to a greater extent in UTI (–/–) mice than in WT mice. These results suggest that UTI protects against acute lung injury induced by bacterial endotoxin, at least partly, through the inhibition of the enhanced local expression of proinflammatory cytokines, chemokines, and ICAM-1.
RileyS, FraserC, DonnellyCA, GhaniAC, Abu-RaddadLJ, HedleyAJ, LeungGM, HoLM, LamTH, ThachTQ, ChauP, ChanKP, LoSV, LeungPY, TsangT, HoW, LeeKH, LauEM, FergusonNM, AndersonRM. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science300: 1961–1966, 2003.
2.
BrighamKL, MeyrickB. Endotoxin and lung injury. Am Rev Respir Dis133: 913–927, 1986.
3.
BlackwellTS, LancasterLH, BlackwellTR, VenkatakrishnanA, ChristmanJW. Chemotactic gradients predict neutrophilic alveolitis in endotoxin-treated rats. Am J Respir Crit Care Med159: 1644–1652, 1999.
4.
ArtigasA, BernardGR, CarletJ, DreyfussD, GattinoniL, HudsonL, LamyM, MariniJJ, MatthayMA, PinskyMR, SpraggR, SuterPM. The American-European Consensus Conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med157: 1332–1347, 1998.
5.
TkalcevicJ, NovelliM, PhylactidesM, IredaleJP, SegalAW, RoesJ. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity12: 201–210, 2000.
SumiH, TakadaY, TakadaA. Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid. Thromb Res11: 747–754, 1977.
9.
WachterE, HochstrasserK. Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography. Hoppe Seylers Z Physiol Chem362: 1351–1355, 1981.
10.
AibikiM, CookJA. Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. Crit Care Med25: 430–434, 1997.
11.
MaeharaK, KanayamaN, HalimA, el MaradnyE, OdaT, FujitaM, TeraoT. Down-regulation of interleukin-8 gene expression in HL60 cell line by human Kunitz-type trypsin inhibitor. Biochem Biophys Res Commun206: 927–934, 1995.
12.
AosasaS, OnoS, MochizukiH, TsujimotoH, UenoC, MatsumotoA. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock15: 101–105, 2001.
13.
ZaitsuM, HamasakiY, TashiroK, MatsuoM, IchimaruT, FujitaI, TasakiH, MiyazakiS. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis181: 1101–1109, 2000.
14.
YanoT, AnrakuS, NakayamaR, UshijimaK. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology98: 465–473, 2003.
15.
MasudaT, SatoK, NodaC, IkedaKM, MatsunagaA, OguraMN, ShimizuK, NagasawaH, MatsuyamaN, IzumiT. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med31: 1987–1992, 2003.
16.
TaniT, AokiH, YoshiokaT, LinKJ, KodamaM. Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial. Crit Care Med21: 925–930, 1993.
17.
KoizumiR, KanaiH, MaezawaA, KandaT, NojimaY, NaruseT. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats. Nephron84: 347–353, 2000.
18.
TakanoH, YoshikawaT, IchinoseT, MiyabaraY, ImaokaK, SagaiM. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med156: 36–42, 1997.
19.
IchinoseT, FuruyamaA, SagaiM. Biological effects of diesel exhaust particles (DEP). II. Acute toxicity of DEP introduced into lung by intratracheal instillation. Toxicology99: 153–167, 1995.
20.
IdellS. Anticoagulants for acute respiratory distress syndrome: can they work?Am J Respir Crit Care Med164: 517–520, 2001.
21.
WeissSJ. Tissue destruction by neutrophils. N Engl J Med320: 365–376, 1989.
22.
UmekiS, NikiY, SoejimaR. Elastase/antielastase systems in pulmonary diseases. Am J Med Sci296: 103–106, 1988.
23.
TetleyTD. New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. Thorax48: 560–565, 1993.
24.
ChapmanHA, RieseRJ, ShiGP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol59: 63–88, 1997.
25.
DengX, WangX, LassonA, SunTZ, SolteszV, AnderssonR. The involvement of multiple protease-antiprotease systems and gut origin sepsis in zymosan-associated endothelial barrier injury and multiple organ dysfunction in rats. Shock16: 298–303, 2001.
26.
TravisJ. Structure, function, and control of neutrophil proteinases. Am J Med84: 37–42, 1988.
27.
YoshimuraK, NakagawaS, KoyamaS, KobayashiT, HommaT. Roles of neutrophil elastase and superoxide anion in leukotriene B4-induced lung injury in rabbit. J Appl Physiol76: 91–96, 1994.
28.
SakamakiF, IshizakaA, UranoT, SayamaK, NakamuraH, TerashimaT, WakiY, TasakaS, HasegawaN, SatoK, NakagawaN, ObataT, KanazawaM. Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med153: 391–397, 1996.
YokoiK, MukaidaN, HaradaA, WatanabeY, MatsushimaK. Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest76: 375–384, 1997.
31.
ParseyMV, TuderRM, AbrahamE. Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol160: 1007–1013, 1998.
32.
GoodmanRB, StrieterRM, MartinDP, SteinbergKP, MilbergJA, MaunderRJ, KunkelSL, WalzA, HudsonLD, MartinTR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med154: 602–611, 1996.
33.
JonesML, MulliganMS, FloryCM, WardPA, WarrenJS. Potential role of monocyte chemoattractant protein 1/JE in monocyte/macrophage-dependent IgA immune complex alveolitis in the rat. J Immunol149: 2147–2154, 1992.
DoerschukCM, QuinlanWM, DoyleNA, BullardDC, VestweberD, JonesML, TakeiF, WardPA, BeaudetAL. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol157: 4609–4614, 1996.
36.
KawamuraT, InadaK, AkasakaN, WakusawaR. Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery. Can J Anaesth43: 456–460, 1996.
